Cargando…

Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters

Maternal endocrine homeostasis is vital to a successful pregnancy, regulated by several hormones such as human chorionic gonadotropin, estrogen, leptin, glucocorticoid, insulin, prostaglandin, and others. Endocrine stress during pregnancy can modulate nutrient availability from mother to fetus, alte...

Descripción completa

Detalles Bibliográficos
Autores principales: Basak, Sanjay, Varma, Saikanth, Duttaroy, Asim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579913/
https://www.ncbi.nlm.nih.gov/pubmed/37854189
http://dx.doi.org/10.3389/fendo.2023.1215353
_version_ 1785121833915252736
author Basak, Sanjay
Varma, Saikanth
Duttaroy, Asim K.
author_facet Basak, Sanjay
Varma, Saikanth
Duttaroy, Asim K.
author_sort Basak, Sanjay
collection PubMed
description Maternal endocrine homeostasis is vital to a successful pregnancy, regulated by several hormones such as human chorionic gonadotropin, estrogen, leptin, glucocorticoid, insulin, prostaglandin, and others. Endocrine stress during pregnancy can modulate nutrient availability from mother to fetus, alter fetoplacental growth and reproductive functions. Endocrine disrupters such as bisphenols (BPs) and phthalates are exposed in our daily life's highest volume. Therefore, they are extensively scrutinized for their effects on metabolism, steroidogenesis, insulin signaling, and inflammation involving obesity, diabetes, and the reproductive system. BPs have their structural similarity to 17-β estradiol and their ability to bind as an agonist or antagonist to estrogen receptors to elicit an adverse response to the function of the endocrine and reproductive system. While adults can negate the adverse effects of these endocrine-disrupting chemicals (EDCs), fetuses do not equip themselves with enzymatic machinery to catabolize their conjugates. Therefore, EDC exposure makes the fetoplacental developmental window vulnerable to programming in utero. On the one hand prenatal BPs and phthalates exposure can impair the structure and function of the ovary and uterus, resulting in placental vascular defects, inappropriate placental expression of angiogenic growth factors due to altered hypothalamic response, expression of nutrient transporters, and epigenetic changes associated with maternal endocrine stress. On the other, their exposure during pregnancy can affect the offspring's metabolic, endocrine and reproductive functions by altering fetoplacental programming. This review highlights the latest development in maternal metabolic and endocrine modulations from exposure to estrogenic mimic chemicals on subcellular and transgenerational changes in placental development and its effects on fetal growth, size, and metabolic & reproductive functions.
format Online
Article
Text
id pubmed-10579913
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105799132023-10-18 Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters Basak, Sanjay Varma, Saikanth Duttaroy, Asim K. Front Endocrinol (Lausanne) Endocrinology Maternal endocrine homeostasis is vital to a successful pregnancy, regulated by several hormones such as human chorionic gonadotropin, estrogen, leptin, glucocorticoid, insulin, prostaglandin, and others. Endocrine stress during pregnancy can modulate nutrient availability from mother to fetus, alter fetoplacental growth and reproductive functions. Endocrine disrupters such as bisphenols (BPs) and phthalates are exposed in our daily life's highest volume. Therefore, they are extensively scrutinized for their effects on metabolism, steroidogenesis, insulin signaling, and inflammation involving obesity, diabetes, and the reproductive system. BPs have their structural similarity to 17-β estradiol and their ability to bind as an agonist or antagonist to estrogen receptors to elicit an adverse response to the function of the endocrine and reproductive system. While adults can negate the adverse effects of these endocrine-disrupting chemicals (EDCs), fetuses do not equip themselves with enzymatic machinery to catabolize their conjugates. Therefore, EDC exposure makes the fetoplacental developmental window vulnerable to programming in utero. On the one hand prenatal BPs and phthalates exposure can impair the structure and function of the ovary and uterus, resulting in placental vascular defects, inappropriate placental expression of angiogenic growth factors due to altered hypothalamic response, expression of nutrient transporters, and epigenetic changes associated with maternal endocrine stress. On the other, their exposure during pregnancy can affect the offspring's metabolic, endocrine and reproductive functions by altering fetoplacental programming. This review highlights the latest development in maternal metabolic and endocrine modulations from exposure to estrogenic mimic chemicals on subcellular and transgenerational changes in placental development and its effects on fetal growth, size, and metabolic & reproductive functions. Frontiers Media S.A. 2023-10-03 /pmc/articles/PMC10579913/ /pubmed/37854189 http://dx.doi.org/10.3389/fendo.2023.1215353 Text en Copyright © 2023 Basak, Varma and Duttaroy https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Basak, Sanjay
Varma, Saikanth
Duttaroy, Asim K.
Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title_full Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title_fullStr Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title_full_unstemmed Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title_short Modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
title_sort modulation of fetoplacental growth, development and reproductive function by endocrine disrupters
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579913/
https://www.ncbi.nlm.nih.gov/pubmed/37854189
http://dx.doi.org/10.3389/fendo.2023.1215353
work_keys_str_mv AT basaksanjay modulationoffetoplacentalgrowthdevelopmentandreproductivefunctionbyendocrinedisrupters
AT varmasaikanth modulationoffetoplacentalgrowthdevelopmentandreproductivefunctionbyendocrinedisrupters
AT duttaroyasimk modulationoffetoplacentalgrowthdevelopmentandreproductivefunctionbyendocrinedisrupters